Factor D Complement Inhibitor Market 2034: Clinical Trials, Medication, FDA Approvals, Companies by DelveInsight
Factor D complement inhibitors companies working in the market are AstraZeneca, Alexion (a subsidiary of AstraZeneca), BioCryst, and others. ALBANY, NY, UNITED STATES, December 4, 2024 /EINPresswire.com/ -- The factor D complement inhibitor …